We will continue to invest in our future growth. In 2010, we expect to invest about 5 % of sales in property, plant and equipment. This will be, relative to sales, in line with the 2009 level.

About 60 % of the capital expenditure budgeted will be invested at Fresenius Medical Care, while Fresenius Kabi and Fresenius Helios will each account for about 20 %. Investments at Fresenius Medical Care will focus on the construction of dialysis clinics and on expanding production capacities. Fresenius Kabi will invest in expanding and maintaining production facilities and in introducing new manufacturing technologies, enabling further improvements in production efficiency. At Fresenius Helios we will be investing primarily in modernizing hospitals and in hospital equipment.

The regional focus of the Group’s investments will be on Europe and North America, which will account for about 50 % and 35 %, respectively. The remainder will be invested in Asia, Latin America, and Africa. About 30 % of the funds will be invested in Germany.

Back to:
Continue reading: